Patient-reported Outcome Measures in Type 1 Diabetes Outpatient Care

Overview

Journal Hippokratia

Specialty General Medicine

Date 2024 Oct 14

PMID 39399403

Authors

J Rochate

Vale do

Affiliations

Soon will be listed here.

Abstract

Methods: A cross-sectional study of adults with T1DM was conducted in the outpatient Endocrinology department between October 2022 and May 2023. Clinical, demographic, and continuous glucose monitoring (CGM) data were collected. Three PROMs were applied: the diabetes psychological adjustment scale (ATT18), the World Health Organization well-being index (WHO-5), and the patient health questionnaire (PHQ-9). Descriptive and bivariate statistical analyses were performed.

Results: We included 56 participants, aged 41.2 ± 14.6 years, 58 % female, and 64 % of medium-high socioeconomic class. The disease duration of the cohort was 21 ± 14.6 years, with 44.6 % on continuous subcutaneous insulin infusion (CSII) and 39.3 % presenting microvascular complications. Glycated hemoglobin of the cohort was 8.0 ± 1.4 %, time in range (TIR) 52 ± 22 %, coefficient of variation (CV) 37 ± 8 %, and median time below range (TBR) 2 %. Individuals on CSII had higher TIR (p =0.03). CV was related to TBR (ρ =0.643, p <0.001). The majority had satisfactory psychological adjustment to diabetes (ATT18 ≥60), which correlated directly with WHO-5 (r =0.511, p <0.001) and inversely with depression symptoms (r =-0.676, p <0.001). No relationships were identified between metabolic control and PROMs (p =0.63).

Conclusions: Including PROMs alongside detailed metabolic evaluation allows for individualized decision-making and active patient participation in diabetes management. These results underscore the importance of preventing depression, promoting well-being, and enhancing diabetes psychological adjustment in these patients, aiming to improve their quality of life. HIPPOKRATIA 2024, 28 (1):17-21.

References

El Malahi A, Van Elsen M, Charleer S, Dirinck E, Ledeganck K, Keymeulen B . Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus. J Clin Endocrinol Metab. 2021; 107(2):e570-e581. DOI: 10.1210/clinem/dgab688. View

Hajos T, Pouwer F, Skovlund S, den Oudsten B, Geelhoed-Duijvestijn P, Tack C . Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus. Diabet Med. 2012; 30(2):e63-9. DOI: 10.1111/dme.12040. View

Topp C, Ostergaard S, Sondergaard S, Bech P . The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015; 84(3):167-76. DOI: 10.1159/000376585. View

Vigersky R, McMahon C . The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technol Ther. 2018; 21(2):81-85. DOI: 10.1089/dia.2018.0310. View

ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D . 6. Glycemic Targets: Standards of Care in Diabetes-2023. Diabetes Care. 2022; 46(Suppl 1):S97-S110. PMC: 9810469. DOI: 10.2337/dc23-S006. View

He C, Levis B, Riehm K, Saadat N, Levis A, Azar M . The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis. Psychother Psychosom. 2019; 89(1):25-37. PMC: 6960351. DOI: 10.1159/000502294. View

Abraham M, de Bock M, Smith G, Dart J, Fairchild J, King B . Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA Pediatr. 2021; 175(12):1227-1235. PMC: 8506294. DOI: 10.1001/jamapediatrics.2021.3965. View

Wilmot E, Close K, Jurisic-Erzen D, Bruttomesso D, Ampudia-Blasco F, Bosnyak Z . Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study. Diabetes Obes Metab. 2021; 23(8):1892-1901. DOI: 10.1111/dom.14416. View

Figueiredo A, Matos T, do Vale S . Monitoring of continuous subcutaneous insulin infusion treatment in Portugal and its implications for diabetes management. Hormones (Athens). 2022; 22(1):87-94. DOI: 10.1007/s42000-022-00412-8. View

10.

Nano J, Carinci F, Okunade O, Whittaker S, Walbaum M, Barnard-Kelly K . A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med. 2020; 37(12):2009-2018. DOI: 10.1111/dme.14286. View

11.

Battelino T, Danne T, Bergenstal R, Amiel S, Beck R, Biester T . Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019; 42(8):1593-1603. PMC: 6973648. DOI: 10.2337/dci19-0028. View

12.

Skrha J, Soupal J, Skrha Jr J, Prazny M . Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016; 17(1):103-10. DOI: 10.1007/s11154-016-9347-2. View

13.

Alvarado-Martel D, Velasco R, Sanchez-Hernandez R, Carrillo A, Javier Novoa F, Maria Wagner A . Quality of life and type 1 diabetes: a study assessing patients' perceptions and self-management needs. Patient Prefer Adherence. 2015; 9:1315-23. PMC: 4576890. DOI: 10.2147/PPA.S87310. View

14.

Beck R, Bergenstal R, Cheng P, Kollman C, Carlson A, Johnson M . The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c. J Diabetes Sci Technol. 2019; 13(4):614-626. PMC: 6610606. DOI: 10.1177/1932296818822496. View

15.

Costantini L, Pasquarella C, Odone A, Colucci M, Costanza A, Serafini G . Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord. 2020; 279:473-483. DOI: 10.1016/j.jad.2020.09.131. View

16.

Renard E, Ikegami H, Daher Vianna A, Pozzilli P, Brette S, Bosnyak Z . The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM. Diabetes Metab Res Rev. 2020; 37(7):e3430. PMC: 8518876. DOI: 10.1002/dmrr.3430. View

17.

Saisho Y . Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. Int J Environ Res Public Health. 2018; 15(5). PMC: 5981986. DOI: 10.3390/ijerph15050947. View

18.

Churruca K, Pomare C, Ellis L, Long J, Henderson S, Murphy L . Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expect. 2021; 24(4):1015-1024. PMC: 8369118. DOI: 10.1111/hex.13254. View

19.

Rodbard D . Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution. Diabetes Technol Ther. 2019; 22(7):492-500. DOI: 10.1089/dia.2019.0440. View

20.

Martin-Delgado J, Guilabert M, Mira-Solves J . Patient-Reported Experience and Outcome Measures in People Living with Diabetes: A Scoping Review of Instruments. Patient. 2021; 14(6):759-773. PMC: 8563512. DOI: 10.1007/s40271-021-00526-y. View